Summary
CME Group Inc.'s 2013 10-K report details a solid operational year marked by a revenue increase driven primarily by higher contract volumes across its various products, including interest rates, equities, foreign exchange, agriculture, energy, and metals. The company's strategic initiatives, focused on global expansion, product innovation, and enhancing its over-the-counter (OTC) and electronic trading capabilities, appear to be yielding positive results. Despite facing a competitive and evolving regulatory landscape, particularly with the ongoing implementation of the Dodd-Frank Act, CME Group demonstrated resilience. The company's strong financial position is supported by consistent clearing and transaction fee revenues and prudent expense management, allowing for continued investment in technology and services that maintain its market leadership. Key financial highlights include a modest increase in total revenues compared to the previous year, driven by a 9% rise in total contract volume. While the average rate per contract saw a slight decrease due to a shift in product mix towards lower-fee interest rate products, the overall revenue growth indicates a healthy operational performance. CME Group also continued its commitment to shareholder returns through consistent dividend payments and strategic capital allocation. The company's diversified product offering and robust electronic trading platform remain key competitive strengths, positioning it to navigate market volatility and regulatory changes effectively.
Financial Highlights
49 data points| Revenue | $2.94B |
| Operating Expenses | $1.30B |
| Operating Income | $1.64B |
| Net Income | $976.80M |
| EPS (Basic) | $2.94 |
| EPS (Diluted) | $2.92 |
| Shares Outstanding (Basic) | 332.68M |
| Shares Outstanding (Diluted) | 334.40M |
Key Highlights
- 1Total revenues increased by 1% to $2.94 billion in 2013, primarily driven by a 9% increase in total contract volume.
- 2Operating income remained strong at $1.64 billion, though slightly lower than $1.69 billion in 2012, reflecting investments in business growth and expenses related to asset sales.
- 3Net income attributable to CME Group increased by 9% to $976.8 million in 2013, with diluted EPS rising to $2.92 from $2.70 in 2012.
- 4Electronic trading continued to dominate, accounting for 86% of contract volume, underscoring the company's technological advantage.
- 5Interest rate products, particularly U.S. Treasury futures and the Eurodollar back 32 futures, showed significant volume growth, indicating increased hedging and speculative activity in response to market volatility.
- 6The company continued to expand its global reach and product offerings, including the acquisition of KCBT and increased ownership in the S&P/Dow Jones Indices joint venture.
- 7Dividends paid to shareholders increased, with a regular quarterly dividend of $0.47 and an additional annual variable dividend of $2.60 declared for 2013.